Reflecting on the evolution of bispecific antibodies in multiple myeloma, Ajai Chari, MD, professor of medicine and director of the Multiple Myeloma Program at the University of C ...

Two-year data confirm DOR/ISL delivers durable viral suppression—even in patients with high viral loads or advanced disease.

Benjamin Lockshin, MD, FAAD, examines how geographic variation in psoriasis patient characteristics and biologic prescribing reflects a complex interplay of insurance access, formulary structure, ...

Benjamin Lockshin, MD, FAAD, outlines the clinical and practical factors driving the dominance of IL-23 inhibitors in biologic initiation, highlighting their favorable safety profile, ease of patient ...

Global pediatric HIV data show dolutegravir links to early modest weight gain that plateaus by year 2, easing concerns and ...

Neurologist visit frequency was modestly higher among cancer cases than controls but declined over time in both settings, ...

A study suggests vitamin D may reduce long COVID symptoms at 8 weeks, although larger trials are needed to confirm benefits ...

Steven Kheloussi, PharmD, explores how smarter clinical tools, multidisciplinary teams, and better care coordination can ...

Capping Medicare beneficiaries’ monthly insulin out-of-pocket costs at $35 was associated with steep reductions in spending ...

ATTAIN demonstrated placebo-adjusted weight reductions of roughly 9–11 percentage points at 72 weeks, with 27.3 lb (12.4%) ...

Chronic stress activates the HPA axis, increasing cortisol and neuropeptides that impair gut barrier integrity, shift ...

Federal pharmacy benefit manager transparency reforms must contend with concentrated pharmaceutical markets that lack ...